Your browser doesn't support javascript.
loading
Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosis.
Barra, Fabio; Ferro Desideri, Lorenzo; Gustavino, Claudio; Ferrero, Simone; Traverso, Carlo Enrico; Nicolò, Massimo.
Afiliação
  • Barra F; Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132, Genoa, Italy. fabio.barra@icloud.com.
  • Ferro Desideri L; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy. fabio.barra@icloud.com.
  • Gustavino C; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
  • Ferrero S; University Eye Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Traverso CE; Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132, Genoa, Italy.
  • Nicolò M; Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132, Genoa, Italy.
Arch Gynecol Obstet ; 306(2): 569-570, 2022 08.
Article em En | MEDLINE | ID: mdl-34989831
Correspondence to the original research entitled "Effects of ranibizumab and zoledronic acid on endometriosis in a rat model" published by Ozdemir et al.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endometriose / Conservadores da Densidade Óssea Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endometriose / Conservadores da Densidade Óssea Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article